WCPO: UC helps Ohio company win FDA approval for ventilators
P&G employees develop low-cost ventilators with help from UC Biomedical Engineering and UC Health
A Cincinnati company received help from the University of Cincinnati to win federal regulatory approval for a new low-cost ventilator to treat patients with COVID-19, according to WCPO.
WCPO spoke to John Molander, president of Venti-Now, about the project to provide ventilators to hospitals to meet increased demand from the global pandemic.
UC Health and UC's College of Engineering and Applied Science helped provide medical testing and consultation to win approval from the Food and Drug Administration for the medical device.
The devices will be manufactured in Dayton and southeastern Indiana for distribution around the world.
Venti-Now is composed of former and current employees at Procter & Gamble Co.
How UC is helping battle COVID-19
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Local 12: Engineers design patch that tells you about your health
January 25, 2023
UC College of Engineering and Applied Science graduate Mark Friedel tells Local 12 that interstitial fluid is the next frontier of continuous health monitoring.
Spectrum News: Therapies make psychedelics more accessible
January 25, 2023
UC postdoctoral researcher Neşe Devenot tells Spectrum News that psychedelics can have therapeutic benefits, but she resists classifying them as medicine.
Spectrum News: FDA proposes annual COVID boosters
January 25, 2023
The FDA is recommending an annual COVID-19 booster shot for most adults and children. Spectrum News interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine to get his reaction to this recommendation.